shortagewatch

Home / Digestive tract and metabolism / Scopolamine

ATC A04AD01 · Other Antiemetics · updated 2 Nov 2026

Scopolamine shortage

As of 2 Nov 2026, Scopolamine has a reported shortage in 1 of the 16 countries we track (United States), covering 1 product from 1 company.

Is there a Scopolamine shortage?

Yes. As of 2 Nov 2026, Scopolamine is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

Countries1/16
Products1packs or presentations
Companies10 listed
Short since3 Nov 202512 months ago
Earliest returnnot givencompany estimate
Main reasonNot stated

Timeline

United States
2026Scopolamine, Transdermal System, 1 mg (NDC 4Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Padagis1

Compared with similar medicines

ATC group A04AD · Other Antiemetics
Aprepitant12/16Scopolamine1/16

Affected products

CountryProductCompanySinceExpected backReason
USScopolamine, Transdermal System, 1 mg (NDC 45802-580-46) discontinuationPadagis US LLC3 Nov 2025not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Scopolamine shortage?

Yes. As of 2 Nov 2026, Scopolamine is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

When will Scopolamine be back in stock?

No return date has been given; United States: no date given. These are company estimates reported to each authority.

Why is Scopolamine in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Scopolamine shortages?

Padagis.